SCHEMBL1169719

SCHEMBL1169719

CC(=O)NNC(=O)c1ccccc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.65
CA9 Q16790 4/20 0.65
L1CAM P32004 1/20 0.61
NPC1 O15118 6/20 0.59
RAB9A P51151 4/20 0.59
KDM4E B2RXH2 4/20 0.59
HTT P42858 3/20 0.59
ALDH1A1 P00352 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
GAA P10253 2/20 0.59
MPO P05164 1/20 0.59
HIF1A Q16665 1/20 0.59
LMNA P02545 3/20 0.55
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
TP53 P04637 2/20 0.53
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29851354 1.00 CA1 (0.65) CA1CA9L1CAMNPC1RAB9A
SCHEMBL77381 0.89 CA1 (0.77) CA1CA9L1CAMNPC1RAB9A
SCHEMBL8015608 0.82 CA1 (0.61) CA1CA9L1CAMNPC1RAB9A
Salacetamide SCHEMBL25410 0.82 KDM4E (0.61) CA1CA9NPC1RAB9AKDM4E
SCHEMBL6636585 0.82 CA1 (0.79) CA1CA9L1CAMNPC1RAB9A
SCHEMBL11324085 0.80 NPC1 (0.63) CA1CA9NPC1RAB9AKDM4E
SCHEMBL23978398 0.80 KDM4E (0.65) CA1CA9L1CAMNPC1RAB9A
SCHEMBL6638020 0.80 NPC1 (0.74) CA1CA9L1CAMNPC1RAB9A
SCHEMBL4218154 0.80 CA1 (0.65) CA1CA9L1CAMNPC1RAB9A
SCHEMBL6634684 0.79 CA1 (0.59) CA1CA9L1CAMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3428229-B1 CURABLE RESIN COMPOSITION, FUEL CELL, AND SEALING METHOD THREE BOND CO LTD (JP) 2022-08-17 EP claimed
CN-108713044-B Polycarbonate resin composition and molded article thereof 出光兴产株式会社 2021-08-17 CN claimed
US-10800952-B2 Curable resin composition, fuel cell, and sealing method THREEBOND CO., LTD. (JP) 2020-10-13 US claimed
EP-0680999-B1 STYRENE RESIN COMPOSITION IDEMITSU KOSAN CO (JP) 1999-03-03 EP claimed
EP-0680999-A1 STYRENE RESIN COMPOSITION IDEMITSU KOSAN COMPANY LIMITED (JP) 1995-11-08 EP claimed
JP-1060676-A None JP disclosed
US-20260138359-A1 SILICONE-THERMOPLASTIC COMPOSITE ARTICLES DOW SILICONES CORP (US) 2026-05-21 US disclosed
US-20260109818-A1 LIQUID SILICONE RUBBER COMPOSITION DOW SILICONES CORP (US) 2026-04-23 US disclosed
US-20260098144-A1 RESIN COMPOSITION, FILM WITH RESIN, PREPREG, SHEET OF METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2026-04-09 US disclosed
US-20250011261-A1 METHOD FOR PRODUCING HEXAFLUORO-1,3-BUTADIENE RESONAC CORPORATION (JP) 2025-01-09 US disclosed
US-20240426048-A1 SILICONE RUBBER COMPOSITION FOR TEXTILE COATING AND SILICONE RUBBER-COATED TEXTILE DOW TORAY CO LTD (JP) 2024-12-26 US disclosed
EP-4431126-A1 HOLLOW FIBER MEMBRANE BLOOD PURIFIER Asahi Kasei Medical Co., Ltd. (JP) 2024-09-18 EP disclosed
US-5643676-A FOR AUTOMOBILES IN STORAGE OR TRANSPORTATION HITACHI CHEMICAL COMPANY, LTD. (JP) 1997-07-01 US disclosed
EP-0763584-A1 COATING-PROTECTIVE FILM HITACHI CHEMICAL CO., LTD. (JP) 1997-03-19 EP disclosed
EP-0748833-A1 STRETCHED POLYSTYRENE FILM, PROCESS FOR PRODUCING THE SAME, AND PHOTOGRAPHIC PROCESS AND OHP FILMS IDEMITSU PETROCHEMICAL CO., LTD. (JP) 1996-12-18 EP disclosed
EP-0742246-A1 STRETCHED POLYSTYRENE FILM AND PROCESS FOR THE PREPARATION OF STRECHTED POLYSTYRENE FILM IDEMITSU PETROCHEMICAL CO., LTD. (JP) 1996-11-13 EP disclosed
EP-0651402-A1 RARE EARTH BOND MAGNET, COMPOSITION THEREFOR, AND METHOD OF MANUFACTURING THE SAME SEIKO EPSON CORPORATION (JP) 1995-05-03 EP disclosed
JP-S6460676-A CURABLE ADHESIVE COMPOSITION NIPPON ZEON CO 1989-03-07 JP disclosed
US-4306930-A INCORPORATING A HYDRAZIDE OR DIHYDRAZIDE AND THEN VULCANIZING IN CONTACT WITH A METAL CIBA-GEIGY CORPORATION (US) 1981-12-22 US disclosed
US-4077948-A N-SALICYLIDENE-N*-SALICYLHYDRAZIDES CIBA-GEIGY CORPORATION (US) 1978-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109818-A1 LIQUID SILICONE RUBBER COMPOSITION MCM5, H1-5, HNRNPH3 CA1 436/4885CA9 862/4885L1CAM 839/4885
US-20260098144-A1 RESIN COMPOSITION, FILM WITH RESIN, PREPREG, SHEET OF METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD ATP1A4, ATP4B, ATP1B3 CA1 570/4885CA9 1729/4885L1CAM 1529/4885
US-20260138359-A1 SILICONE-THERMOPLASTIC COMPOSITE ARTICLES MLST8, MCM7, RPL23 CA1 1476/4885CA9 4339/4885L1CAM 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.